Andrew R, Sujith S, Kimme LH, James BG
Endpoints and populations differ
Whether you're just starting out or months into your journey, knowing what others are experiencing can help you feel less alone and more prepared
Im always looking for the regulatory gaps and the trends where industry may be getting ahead of the science, so I certainly see some risks with claims being made in the GLP-1 dietary supplement space, said attorney Joseph Lyon, founding partner of The Lyon Firm
Dysesthesia occurred in 8.8% and 20.9% (9 mg and 12 mg, respectively) of patients treated with retatrutide, compared to 0.7% with placebo
The study included dose escalation as recommended by the manufacturer, beginning with a quarter of the full dose (naltrexone 8 mg/bupropion 90 mg once daily) at week 1 and gradual increment weekly to the full dose (naltrexone 32 mg/bupropion 360 mg in 2 divided doses) at week 4